Developing new contraceptive methods for men and women
BIOLOGICAL TESTING FACILITY - DISCOVERY, CLINICAL FORMULATION, AND MANUFACTURE OF CONTRACEPTIVES
This study is working on developing new, safe, and effective birth control options that help prevent pregnancy by affecting ovulation and sperm function, so people can have more affordable and accessible choices for contraception.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sri International NIH-funded |
| Lab location | 1 site (Menlo Park, United States) |
| Project ID | NIH-11177532 on NIH RePORTER |
What this research studies
This research focuses on creating safe and effective contraceptives by disrupting normal ovulation and sperm function. The Biological Testing Facility plays a key role in evaluating new drug formulations and delivery systems through various preclinical activities, including laboratory assays and animal studies. By managing the development process, the facility aims to produce contraceptive compounds that meet regulatory standards for clinical trials. Patients may benefit from innovative contraceptive options that are affordable and accessible.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals seeking new contraceptive options, particularly those interested in innovative methods.
Not a fit: Patients who are not seeking contraceptive solutions or those who have contraindications to hormonal contraceptives may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new contraceptive methods that are safer and more effective for patients.
How similar studies have performed: Previous research in contraceptive development has shown promise, indicating that innovative approaches can lead to successful new methods.
Where this research is happening
Menlo Park, United States
- Sri International — Menlo Park, United States (Active)
Researchers
- Principal investigator: Bunin, Deborah — Sri International
- Study coordinator: Bunin, Deborah
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.